Physician profile
Douglas Mcaffee Sheets
NPI 1023063658
$43,522.00
in general payments reported to CMS, 2019-2025
9 companies · $57.05 in 2025
The $57.05 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.62 · 2020: $284 · 2021: $3,686 · 2022: $9,622 · 2023: $23K · 2024: $6,726 · 2025: $57.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $30K · Food and Beverage: $96.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $29,805.81 |
| Food and Beverage | $96.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hiossen, INC. | $43,005.81 | 2021-2024 | |
| Dentsply Sirona INC | $229.97 | 2020-2025 | Surefil Sdr Flow+ Bulk Fill Flowable, X-Smart, Consumable Dentistry |
| Patterson Companies, INC. | $149.50 | 2020 | |
| Ultradent Products INC | $43.24 | 2019-2021 | |
| Neoss, INC. | $42.30 | 2021-2022 | |
| Voco America INC. | $14.49 | 2025 | Admira Fusion X-Tra, Voco Profluorid Varnish, Futurabond U |
| Colgate Oral Pharmaceuticals, INC. | $12.96 | 2021 | |
| Kulzer, LLC | $12.63 | 2019 | |
| Implant Direct Sybron International LLC | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Sheets listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.